GNH USA

Europe — EMA

Ismo Retard

GNH USA supplies Ismo Retard (Isosorbide Mononitrate), an organic nitrate for prophylaxis of angina pectoris. Request a quote for supply to your institution.

Isosorbide Mononitrate

Request sourcing

1
Pack/s

What is Isosorbide Mononitrate?

Isosorbide Mononitrate, the active ingredient in Ismo Retard, is an organic nitrate presented as an oral tablet for oral use. It is used to prevent episodes of angina pectoris in adults.

GNH USA supplies Ismo Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Isosorbide Mononitrate used for?

Ismo Retard belongs to the organic nitrate class and is employed in the management of coronary artery disease and related anginal conditions.

Stable angina: reduces the frequency and severity of chest pain episodes. Chronic ischemic heart disease: improves exercise tolerance by lowering myocardial oxygen demand. Prophylaxis of angina pectoris: maintains long‑term prevention of anginal attacks.

What are the side effects of Isosorbide Mononitrate?

Ismo Retard may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Headache: often transient and related to vasodilation. - Dizziness or light‑headedness: especially on standing. - Flushing: warm sensation of the skin. - Nausea or abdominal discomfort. - Low blood pressure: mild orthostatic hypotension. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: can lead to syncope. - Acute myocardial infarction: rare but reported. - Allergic reactions: rash, itching, or swelling. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Life‑threatening arrhythmias. - Liver dysfunction: abnormal hepatic enzymes.

What precautions apply to Isosorbide Mononitrate?

Before initiating Ismo Retard, clinicians should consider several safety aspects.

Cardiovascular assessment: evaluate baseline blood pressure and heart rate. Concomitant nitrate use: avoid combined therapy to prevent profound hypotension. Renal impairment: monitor renal function and adjust dose if needed. Hepatic impairment: use with caution in patients with liver disease. Pregnancy and lactation: safety not established; discuss risks with prescriber. Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

What does Isosorbide Mononitrate interact with?

Ismo Retard can interact with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other organic nitrates (e.g., nitroglycerin): risk of severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause dangerous blood‑pressure drops.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, beta‑blockers): additive blood‑pressure lowering effect. - Diuretics: increase risk of dehydration and hypotension. - Alcohol: can enhance vasodilatory effects and dizziness.

Frequently asked questions

What is Ismo Retard used for?+
Ismo Retard contains isosorbide mononitrate, an oral antianginal agent prescribed to prevent episodes of angina pectoris in patients with coronary artery disease. It helps reduce the frequency of chest pain by improving blood flow to the heart muscle.
How does isosorbide mononitrate work?+
Isosorbide mononitrate is converted in the body to nitric oxide, which relaxes vascular smooth muscle through the cyclic GMP pathway. This vasodilation lowers cardiac preload and afterload, decreasing myocardial oxygen demand and relieving anginal symptoms.
What is the usual dose of Ismo Retard?+
The specific dose of Ismo Retard is determined by the prescribing clinician based on the individual’s medical condition, response, and tolerability. Dosage may be started low and titrated, but exact amounts should follow the prescriber’s instructions.
Is Ismo Retard safe in pregnancy or breastfeeding?+
Safety data for isosorbide mononitrate during pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Ismo Retard from GNH USA?+
To request Ismo Retard, submit an enquiry on the product page at gnh-usa.com indicating the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Ismo Retard compare with other antianginal drugs?+
Ismo Retard belongs to the organic nitrate class, offering once‑daily dosing and a longer half‑life compared with short‑acting nitrates like nitroglycerin. Unlike beta‑blockers or calcium‑channel blockers, it primarily provides vasodilation without directly affecting heart rate, making it a useful option for patients who need nitrate therapy without additional cardiac rate control.
How should Ismo Retard be stored and handled?+
Store Ismo Retard tablets at ambient temperature, preferably below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children. No refrigeration is required.
How is Ismo Retard administered?+
Ismo Retard is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance on timing, especially if other nitrate medications are prescribed.
What are the most serious risks to watch for while taking Ismo Retard?+
The most serious risks include severe hypotension, which can cause fainting or shock, and rare allergic reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, rash, or swelling of the face or throat.
Who should not use Ismo Retard?+
Ismo Retard should be avoided in patients with known hypersensitivity to isosorbide mononitrate or other organic nitrates, those taking concurrent nitrate therapy, and individuals with severe anemia or recent head injury. Clinicians must also assess suitability in patients with significant hypotension or uncontrolled heart failure.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide Mononitrate
Route
Oral Use
Manufacturer
Pharmakern Portugal – Produtos Farmacêuticos, Sociedade Unipessoal, Lda.
Origin
EU

Related products